| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.159 | 9.873 | 15.271 | 21.637 | 20.301 | 17.880 | 22.821 | 25.763 | 33.774 | 24.763 |
| Total Income - EUR | 9.159 | 11.877 | 15.271 | 21.637 | 20.301 | 17.880 | 22.821 | 25.763 | 33.774 | 24.763 |
| Total Expenses - EUR | 12.265 | 10.047 | 12.155 | 17.821 | 16.515 | 14.509 | 16.826 | 20.629 | 25.846 | 16.993 |
| Gross Profit/Loss - EUR | -3.106 | 1.830 | 3.116 | 3.817 | 3.786 | 3.371 | 5.995 | 5.134 | 7.928 | 7.770 |
| Net Profit/Loss - EUR | -3.381 | 1.474 | 1.760 | 3.281 | 3.177 | 2.872 | 5.310 | 4.361 | 6.660 | 6.713 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ovirux Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.961 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 50.510 | 54.503 | 58.183 | 55.903 | 56.196 | 52.392 | 47.362 | 42.937 | 30.113 | 22.596 |
| Inventories | 50.424 | 54.354 | 51.142 | 48.921 | 49.340 | 45.776 | 40.626 | 36.149 | 21.816 | 15.324 |
| Receivables | 0 | 0 | 6.962 | 6.835 | 6.702 | 6.575 | 6.429 | 6.449 | 6.430 | 6.394 |
| Cash | 86 | 149 | 78 | 147 | 154 | 41 | 307 | 338 | 1.866 | 879 |
| Shareholders Funds | -29.852 | -28.074 | -25.839 | -22.083 | -18.479 | -15.257 | -9.608 | -5.277 | 1.399 | 8.104 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 83.544 | 82.577 | 84.022 | 77.986 | 74.675 | 67.649 | 56.971 | 48.214 | 28.714 | 14.492 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Ovirux Srl